Indefinite Delivery Contract SPE2DX15D6910

The Indefinite Delivery Contract (IDC) SPE2DX15D6910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The single-award IDC, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. This IDC serves as the primary vehicle for the DLA to efficiently procure essential pharmaceutical and medical supplies for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. In addition, Amerisourcebergen Drug Corp holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, to provide similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.